iRhythm Holdings (IRTC) Free Cash Flow Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -109.40% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 363.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 108.16% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 29.12% |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | -257.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -257.77% |
| Dec 31, 2025 | 16.96% |
| Sep 30, 2025 | 896.35% |
| Jun 30, 2025 | -62.57% |
| Mar 31, 2025 | 87.02% |
| Dec 31, 2024 | 122.00% |
| Sep 30, 2024 | -307.41% |
| Jun 30, 2024 | 471.13% |
| Mar 31, 2024 | -57.76% |
| Dec 31, 2023 | -260.18% |
| Sep 30, 2023 | 145.57% |
| Jun 30, 2023 | 122.62% |
| Mar 31, 2023 | -0.17% |
| Dec 31, 2022 | 298.94% |
| Sep 30, 2022 | -160.98% |
| Jun 30, 2022 | -155.97% |
| Mar 31, 2022 | 15.08% |
| Dec 31, 2021 | -423.98% |
| Sep 30, 2021 | -18.20% |
| Jun 30, 2021 | 47.58% |
| Mar 31, 2021 | -78.70% |
| Dec 31, 2020 | 132.70% |
| Sep 30, 2020 | 226.44% |
| Jun 30, 2020 | -383.50% |
| Mar 31, 2020 | -36.59% |
| Dec 31, 2019 | -184.30% |
| Sep 30, 2019 | 35.59% |
| Jun 30, 2019 | 65.90% |
| Mar 31, 2019 | -31.32% |
| Dec 31, 2018 | -26.59% |
| Sep 30, 2018 | -51.84% |
| Jun 30, 2018 | -284.23% |
| Mar 31, 2018 | -89.73% |
| Dec 31, 2017 | -146.49% |
| Sep 30, 2017 | -39.28% |
| Jun 30, 2017 | 54.57% |
| Mar 31, 2017 | 25.37% |
| Dec 31, 2016 | 67.90% |